Role of Probiotics in Pediatric Patients with Helicobacter pylori Infection: A Comprehensive Review of the Literature
- 3 March 2010
- journal article
- review article
- Published by Wiley in Helicobacter
- Vol. 15 (2) , 79-87
Abstract
Background: The current guidelines suggest the use of triple therapy as first choice treatment of Helicobacter pylori infection, although the eradication failure rate is more than 30%. Current interest in probiotics as therapeutic agents against H. pylori is stimulated not only by the clinical data showing efficacy of some probiotics in different gastrointestinal diseases but also by the increasing resistance of pathogenic bacteria to antibiotics, thus the interest for alternative therapies is a real actual topic.Aim: To review in vitro and in vivo studies on the role of probiotics in H. pylori infection focusing on the paediatric literature.Materials and methods: Pre‐clinical and clinical paediatric studies in English assessing the role of probiotics in H. pylori infection identified by MEDLINE search (1950–2009) were reviewed.Results: In vitro studies demonstrated an inhibitory activity of probiotics on H. pylori growth and that this effect is extremely strain specific. Available data in children indicate that probiotics seems to be efficacious for the prevention of antibiotic associated side‐effects, and might be of help for the prevention of H. pylori complications by decreasing H. pylori density and gastritis, and for the prevention of H. pylori colonization or re‐infection by inhibiting adhesion to gastric epithelial cells. There is no clear evidence that probiotics may increase the H. pylori eradication rate.Conclusion: Both in vitro and in vivo studies provide evidence that probiotics may represent a novel approach to the management of H. pylori infection.Keywords
This publication has 70 references indexed in Scilit:
- Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factorsBMC Microbiology, 2009
- A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in childrenActa Paediatrica, 2008
- The Effects of Probiotics on PPI‐Triple Therapy for Helicobacter pylori EradicationHelicobacter, 2008
- The Effects of Probiotics on Feeding Tolerance, Bowel Habits, and Gastrointestinal Motility in Preterm NewbornsThe Journal of Pediatrics, 2008
- L‐Lactic Acid Secreted from Gastric Mucosal Cells Enhances Growth of Helicobacter pyloriHelicobacter, 2007
- Efficacy and Safety of Saccharomyces boulardii in the 14‐day Triple Anti‐Helicobacter pylori Therapy: A Prospective Randomized Placebo‐Controlled Double‐Blind StudyHelicobacter, 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trialAlimentary Pharmacology & Therapeutics, 2004
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteriaJournal of Applied Bacteriology, 1995